Omega-3
Present naturally
Studied for its relevance to membrane fluidity, inflammatory balance, and recovery-oriented signalling.
A concise view of CEOVIA's bioactive architecture, support model, and clinical rationale — shaped for practitioners, clinics, and professional partners.
The Clinical Philosophy
CEOVIA is built on a simple principle: visible wellness rarely belongs to one isolated pathway. Skin quality, cellular resilience, energy steadiness, and immune balance tend to move together.
That is why the platform is framed as a structured daily programme, not a single-claim supplement. The intention is to support the biological terrain behind whole-body vitality.
Ingredient-level literature around Himalayan Sea Buckthorn suggests broad systems relevance. CEOVIA translates that complexity into a clearer, more usable protocol.
Clinical value is easier to interpret when support is coordinated across systems rather than reduced to one symptom or one isolated input.
Mechanism of Action
The value of the ingredient matrix is best understood in layers: what it may support at the cellular level, how that translates across systems, and how a protocol can help make those outcomes observable.
This is not framed as supplementation alone. It is a structured support model designed to begin at the membrane level and extend outward across broader systems.
Bioactive Intelligence
CEOVIA is positioned around a full-spectrum lipid and phytonutrient profile. Its value lies not in a single hero compound, but in the coordinated relevance of the matrix.
| Omega | Concentration | Primary Clinical Role |
|---|---|---|
| Omega-3 | Present naturally | Studied for its relevance to membrane fluidity, inflammatory balance, and recovery-oriented signalling. |
| Omega-6 | Present naturally | Relevant to barrier structure, surface lipid architecture, and broader skin-support physiology. |
| Omega-7 | Approx. 40% | A rarer fatty acid discussed in the literature in relation to epithelial support, tissue comfort, and surface resilience. |
| Omega-9 | Present naturally | Included within the broader lipid profile that supports whole-system structural and metabolic relevance. |
Present naturally
Studied for its relevance to membrane fluidity, inflammatory balance, and recovery-oriented signalling.
Present naturally
Relevant to barrier structure, surface lipid architecture, and broader skin-support physiology.
Approx. 40%
A rarer fatty acid discussed in the literature in relation to epithelial support, tissue comfort, and surface resilience.
Present naturally
Included within the broader lipid profile that supports whole-system structural and metabolic relevance.
This is not a simple formulation. It is a biological matrix whose value comes from how the compounds relate to one another.
| Bioactive | Category | Clinical Role |
|---|---|---|
| Palmitoleic Acid | Fatty Acid | Studied for epithelial support, surface comfort, and barrier-related resilience. |
| Alpha-Linolenic Acid | Essential Lipid | Associated with membrane function and broader inflammatory balance. |
| Linoleic Acid | Essential Lipid | Relevant to barrier lipid structure and skin integrity support. |
| Oleic Acid | Monounsaturated Lipid | Contributes to the overall lipid environment and cellular flexibility. |
| Tocopherols | Vitamin E Complex | Studied for antioxidant support and protection from oxidative load. |
| Carotenoids | Phytonutrient | Support antioxidant defence and are frequently discussed in skin-health literature. |
| Phytosterols | Plant Sterol | Studied for membrane-related support and systemic inflammatory balance. |
| Polyphenols | Phenolic Compounds | Relevant to oxidative buffering and broader cellular protection pathways. |
| Flavonoids | Plant Bioactives | Studied for vascular, antioxidant, and adaptive resilience support. |
| Phospholipids | Structural Lipid | Important to membrane architecture and transport dynamics. |
| Trace Minerals | Micronutrients | Provide cofactors that support biological efficiency and recovery processes. |
| Amino Acids | Matrix Components | Contribute to broader structural and signalling context within the extract matrix. |
| Organic Acids | Supportive Compounds | Part of the broader ingredient profile linked to metabolic and antioxidant relevance. |
| Xanthophyll Pigments | Carotenoid Family | Associated with antioxidant activity and tissue-level protection mechanisms. |
| Minor Polar Lipids | Lipid Fraction | Part of the complexity that distinguishes a full-spectrum extract from isolated fractions. |
Studied for epithelial support, surface comfort, and barrier-related resilience.
Associated with membrane function and broader inflammatory balance.
Relevant to barrier lipid structure and skin integrity support.
Contributes to the overall lipid environment and cellular flexibility.
Studied for antioxidant support and protection from oxidative load.
Support antioxidant defence and are frequently discussed in skin-health literature.
Studied for membrane-related support and systemic inflammatory balance.
Relevant to oxidative buffering and broader cellular protection pathways.
Studied for vascular, antioxidant, and adaptive resilience support.
Important to membrane architecture and transport dynamics.
Provide cofactors that support biological efficiency and recovery processes.
Contribute to broader structural and signalling context within the extract matrix.
Part of the broader ingredient profile linked to metabolic and antioxidant relevance.
Associated with antioxidant activity and tissue-level protection mechanisms.
Part of the complexity that distinguishes a full-spectrum extract from isolated fractions.
90-Day System
The structure is designed to help practitioners frame expectation, adherence, and observation over a meaningful time horizon.
Phase 1
The first phase is designed around consistency and biological exposure. This period is best framed as foundational rather than outcome-led.
Early changes may be subtle and are best interpreted as an adjustment period rather than a visible shift.
Phase 2
With daily intake established, the middle phase supports the conditions where barrier quality, resilience, and tissue steadiness may become more noticeable.
This is often the phase where ingredient-level support may begin to feel more coherent across comfort, steadiness, and surface quality.
Phase 3
The final phase is about reinforcing stability. The protocol encourages observation of durability rather than chasing an early response.
The goal is a more sustainable pattern of support that fits a structured wellness routine rather than short-cycle use.
The 90-day format is a protocol choice, not a quick-cycle promise. It creates a practical window for consistency, observation, and a more disciplined interpretation of experience.
Clinical Framework
These pillars are not framed as separate product claims. They are a practitioner-facing way to understand how ingredient-level evidence clusters across whole-body support domains.
Mechanism
The lipid matrix appears relevant to epithelial integrity, surface resilience, and oxidative balance.
Supporting Bioactives
Omega-7, linoleic acid, carotenoids, tocopherols.
Outcome Statement
May help support a stronger-looking barrier, greater surface comfort, and more consistent-looking skin over time.
Research Gateway
The research landscape around Sea Buckthorn is broad. For web clarity, it is best organised into domains that practitioners can scan quickly without losing scientific context.
The research described here reflects published ingredient-level evidence surrounding Himalayan Sea Buckthorn and related bioactive fractions. It should not be read as proof of finished-product efficacy for CEOVIA. Clinical judgment and regulatory review remain essential.
Partner Programme
CEOVIA partners with a selective network of clinics, dermatologists, integrative practitioners, and wellness professionals who share a commitment to evidence-based, whole-body care.